Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Hypersensitivity Reaction

  Free Subscription


22.06.2026

1 Acta Derm Venereol
12 Allergy
1 Am J Respir Crit Care Med
4 Ann Allergy Asthma Immunol
1 Ann Emerg Med
1 Arch Pediatr
2 BMC Pediatr
2 Chest
3 Contact Dermatitis
2 Eur Respir J
2 Int Arch Allergy Immunol
2 J Allergy Clin Immunol
4 J Am Acad Dermatol
12 J Asthma
1 J Invest Dermatol
1 J Pediatr
2 Pediatr Dermatol
4 PLoS One
2 Respir Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Derm Venereol

  1. AUGUSTIN M, Amerio P, Bewley A, Gieler U, et al
    Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment.
    Acta Derm Venereol. 2026;106:0066.
    PubMed         Abstract available


    Allergy

  2. HEARN AP, Slinger C, Butler JM, Haines J, et al
    Algorithms in Allergy: Diagnosis of Concomitant Inducible Laryngeal Obstruction in Adults With Asthma.
    Allergy. 2026 Jun 19. doi: 10.1111/all.70425.
    PubMed        

  3. DAO-SIEBEL T, Knote C, Muller C, Erbertseder T, et al
    Postcode-Level Variation and Environmental Determinants of Respiratory Allergies in a Large German Cohort.
    Allergy. 2026 Jun 17. doi: 10.1111/all.70406.
    PubMed         Abstract available

  4. GU W, Zhang X, Wang Y, Wang H, et al
    Epithelial Fucosylation Drives Airway Barrier Dysfunction and Allergic Inflammation via a FUT1 -CDH12 Axis.
    Allergy. 2026 Jun 17. doi: 10.1111/all.70413.
    PubMed         Abstract available

  5. CAPELIN-JONES R, Brough H
    Reframing Allergy Prevention: Does Colostrum Hold the Key?
    Allergy. 2026 Jun 16. doi: 10.1111/all.70409.
    PubMed        

  6. RYCZAJ K, Leung DYM, Venter C, Sozanska B, et al
    Emollient Formulations and Skin Barrier Practices in the Context of Eczema and Food Allergy Prevention.
    Allergy. 2026 Jun 16. doi: 10.1111/all.70404.
    PubMed         Abstract available

  7. REHBINDER EM, Vettukattil R, Rueegg CS, Carlsen KCL, et al
    Maternal Body Mass Index, Offspring Impaired Skin Barrier Function, Allergic Sensitization, and Bronchial Obstruction.
    Allergy. 2026 Jun 15. doi: 10.1111/all.70408.
    PubMed        

  8. NACHSHON L, Blom WM, Bijlsma S, Goldberg MR, et al
    Cashew Reaction Thresholds, Its Predictors, and Very Low Validated Safe Doses, in a Large Allergic Population (Nut CRACKER Study).
    Allergy. 2026 Jun 12. doi: 10.1111/all.70412.
    PubMed         Abstract available

  9. ENGEROFF P, Gharailoo Z, Vogel M, Bachmann MF, et al
    A Case for Anti-IgE Vaccination.
    Allergy. 2026;81:2001-2013.
    PubMed         Abstract available

  10. JUTEL M, Klimek L, Gerstlauer M, Troyke D, et al
    A One-Strength Dose Escalation Regimen for Birch Pollen Subcutaneous Immunotherapy Is Safe and Tolerable in Children, Adolescents, and Adults.
    Allergy. 2026;81:2079-2088.
    PubMed         Abstract available

  11. COHEN CG, Toscano-Rivero D, Ahmed EA, Al Ali A, et al
    Autoclaved Peanuts Exhibit Reduced Immunoglobulin E Binding and Improved Oral Tolerability.
    Allergy. 2026;81:2133-2144.
    PubMed         Abstract available

  12. DIDIER A, Juhl RG, Dalgaard T, Chartier A, et al
    Five-Grass-Pollen Sublingual Immunotherapy Drops Are Efficacious and Well Tolerated in Adults: The RHAPSODY Phase III Trial.
    Allergy. 2026;81:2123-2132.
    PubMed         Abstract available

  13. SINGH N, Kesselring J, Humphrey J, Herlihy L, et al
    Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1-4-Year-Old Children.
    Allergy. 2026;81:2089-2102.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  14. FOPPIANO F, Bock A, Beerweiler C, Urner K, et al
    Early neutrophil and persistent eosinophil-associated gene signature in childhood asthma.
    Am J Respir Crit Care Med. 2026 Mar 27:aamag142. doi: 10.1093.
    PubMed         Abstract available


    Ann Allergy Asthma Immunol

  15. FONACIER L, Mawhirt S, Stern H, Roellke E, et al
    Precision Medicine in Atopic Dermatitis: Present and Future.
    Ann Allergy Asthma Immunol. 2026 Jun 13:S1081-1206(26)00266.
    PubMed        

  16. WITT B, Cheung R, Jaffery S, Rukasin CR, et al
    Practice Trends in Allergy and Immunology in the United States from 2015 to 2023.
    Ann Allergy Asthma Immunol. 2026 Jun 12:S1081-1206(26)00268.
    PubMed        

  17. KING C, Zhu J, Pappalardo AA, Frazier M, et al
    Geospatial and Insurance Barriers to Allergist Access Across the Midwest.
    Ann Allergy Asthma Immunol. 2026 Jun 12:S1081-1206(26)00270.
    PubMed         Abstract available

  18. PEPPER EA, Schornack BJ, Zamani M, McMurray JC, et al
    Longitudinal Prescribing Patterns of Mammalian Allergen Immunotherapy Across the U.S. Military Healthcare System from 2005-2024.
    Ann Allergy Asthma Immunol. 2026 Jun 13:S1081-1206(26)00267.
    PubMed        


    Ann Emerg Med

  19. DAVE S, Green-Hopkins I, Bardach NS, Grupp-Phelan J, et al
    Dexamethasone Treatment Regimen and Clinical Outcomes in Children With Asthma Exacerbations.
    Ann Emerg Med. 2026 Jan 22:S0196-0644(25)01451.
    PubMed         Abstract available


    Arch Pediatr

  20. CHEN L, Wang Y, Zhao B, Zhou Y, et al
    Exclusively nurse-led interventions for pediatric asthma: A systematic review and meta-analysis of randomized controlled trials.
    Arch Pediatr. 2026;33:105481.
    PubMed         Abstract available


    BMC Pediatr

  21. YU Y, Liu W, Li X, Chang T, et al
    IL-33 associates with type 2 burden and lung function in paediatric asthma, alongside exploratory IL-33-linked lipid changes.
    BMC Pediatr. 2026 Apr 30. doi: 10.1186/s12887-026-06947.
    PubMed         Abstract available

  22. ZHANG H, Zhou L, Chen B, Qiu W, et al
    Multifactorial analysis of allergen-specific IgE sensitization in children with allergic diseases in Suzhou, China.
    BMC Pediatr. 2026 Jun 17. doi: 10.1186/s12887-026-07166.
    PubMed         Abstract available


    Chest

  23. RIEMANN S, Meulmeester FL, Mailhot-Larouche S, Ramakrishnan S, et al
    Sex does not modify prediction of asthma attacks by clinical risk factors and Type-2 biomarkers.
    Chest. 2026 Jan 30:S0012-3692(26)00131-5. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available

  24. BERTELS X, Scadding GK, Backer V, Lau S, et al
    Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by the European Forum for Research and Education in Allergy and Airways Diseases.
    Chest. 2026;169:1641-1652.
    PubMed         Abstract available


    Contact Dermatitis

  25. CHUMSAENGCHOTSAKUL C, Thantiworasit P, Mongkolpathumrat P, Klaewsongkram J, et al
    Oral Site-Specific Patch Testing Directly at the Fixed Drug Eruption Site in Drug Allergy Investigation.
    Contact Dermatitis. 2026 Jun 16. doi: 10.1111/cod.70206.
    PubMed        

  26. DE MARCHI S, Cecchin E, De Marchi SU, Sechi LA, et al
    Long-Term Risk of Allergic Contact Dermatitis in Children With Atopic Respiratory Disease When They Reach Adulthood.
    Contact Dermatitis. 2026 Jun 15. doi: 10.1111/cod.70198.
    PubMed         Abstract available

  27. SBARRA G, Demichele G, Ambrogio F, Meduri AR, et al
    Allergic Contact Dermatitis With Erythema Multiforme-Like Features Induced by Isoconazole Nitrate.
    Contact Dermatitis. 2026 Jun 12. doi: 10.1111/cod.70204.
    PubMed        


    Eur Respir J

  28. RIEMANN S, Matthys I, Maes T, Lapauw B, et al
    Obesity and asthma: obesity causes and aggravates asthma across the entire type-2 inflammation spectrum.
    Eur Respir J. 2026 Feb 19:2502687. doi: 10.1183/13993003.02687-2025.
    PubMed         Abstract available

  29. SUN X, Liao Y, Wu J, Liu Y, et al
    EcN-Sj16-Exo ameliorates experimental asthma by inhibiting eosinophil extracellular traps formation via N-WASP upregulation.
    Eur Respir J. 2026 Feb 19:2500948. doi: 10.1183/13993003.00948-2025.
    PubMed         Abstract available


    Int Arch Allergy Immunol

  30. ERCAN N, Tekeli A
    Clinical Characteristics and Severity of Pediatric Anaphylaxis in the Emergency Department: A Six-Year Study Based on WAO Criteria.
    Int Arch Allergy Immunol. 2026 Jun 15:1-22. doi: 10.1159/000552773.
    PubMed         Abstract available

  31. SHA J, Liu Y, Yuan Y, Sun L, et al
    Long-term efficacy beyond 10 years of subcutaneous immunotherapy for house-dust-mite-induced allergic rhinitis: A real-world evidence study.
    Int Arch Allergy Immunol. 2026 Jun 18:1-17. doi: 10.1159/000552898.
    PubMed         Abstract available


    J Allergy Clin Immunol

  32. LIANG J, An X, Yang Y, Wang N, et al
    HECT E3 ubiquitin ligase SMURF2 orchestrates FcepsilonRI-dependent mast cell activation and allergic responses.
    J Allergy Clin Immunol. 2026 Jun 12:S0091-6749(26)00412.
    PubMed         Abstract available

  33. BIEBER T, Bochner BS, Boyce JA, Kabashima K, et al
    Highlights from the 2025 Symposium of the Collegium Internationale Allergologicum.
    J Allergy Clin Immunol. 2026 Jun 12:S0091-6749(26)00415.
    PubMed        


    J Am Acad Dermatol

  34. GOLDBERG MS, Lebwohl MG
    RE: Comment on ''The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial''.
    J Am Acad Dermatol. 2026 Jun 18:S0190-9622(26)02949.
    PubMed        

  35. ZHANG Q, Li W, Liu M, Sun Y, et al
    Impact of Janus Kinase Inhibitors on Patch Testing in Patients with Moderate-to-Severe Atopic Dermatitis: A Retrospective Study.
    J Am Acad Dermatol. 2026 Jun 18:S0190-9622(26)02939.
    PubMed        

  36. SMALE NE, Karagounis TK, Milam EC, Cohen DE, et al
    Allergic Contact Dermatitis to Personal Care Products: A Focus on Established and Emerging Allergens.
    J Am Acad Dermatol. 2026 Jun 17:S0190-9622(26)02907.
    PubMed         Abstract available


  37. Correction to Topical therapies for atopic dermatitis. Journal of the American Academy of Dermatology 2026 May;94(5S)S31-S34.
    J Am Acad Dermatol. 2026 Jun 5:S0190-9622(26)02842.
    PubMed        


    J Asthma

  38. SCHARFENBERGER T, Wang X, Berglas R, Kazi A, et al
    Evaluating the Impact of Specialty Pharmacies on Access to Biologics in Patients with Moderate-to-Severe Asthma.
    J Asthma. 2026 Feb 17:1-14. doi: 10.1080/02770903.2026.2633363.
    PubMed         Abstract available

  39. CHEN J, Li X
    Cumulative Effects of Adverse Social Determinants of Health on Asthma Risk: Evidence from NHANES.
    J Asthma. 2026 Feb 19:1-16. doi: 10.1080/02770903.2026.2633358.
    PubMed         Abstract available

  40. HAYASHI Y, Tanabe N, Marumo S, Morita K, et al
    Symptomatic sex differences in patients with severe asthma free of exacerbations and maintenance oral corticosteroids under biologic treatment.
    J Asthma. 2026 Feb 19:1-10. doi: 10.1080/02770903.2026.2633361.
    PubMed         Abstract available

  41. NISHIMURA T, Suzukawa M, Oshima N, Tashimo H, et al
    Tezepelumab is effective in older patients with type 2 severe asthma, and baseline serum cytokine levels may be useful in predicting the efficacy of tezepelumab.
    J Asthma. 2026 Feb 19:1-13. doi: 10.1080/02770903.2026.2633364.
    PubMed         Abstract available

  42. DENG Y, Zhao J, Tian R, Liu L, et al
    Impact of Weight Loss on Obese Children and Adolescents with Asthma: A Systematic Review and Meta-Analysis.
    J Asthma. 2026 Feb 20:1-17. doi: 10.1080/02770903.2026.2633357.
    PubMed         Abstract available

  43. WU M, Fu P, Jiang G, Zhou Z, et al
    Association between pan-immune-inflammation value and asthma all-cause-mortality in American adults: NHANES 1999-2018.
    J Asthma. 2026 Feb 20:1-12. doi: 10.1080/02770903.2026.2633352.
    PubMed         Abstract available

  44. CHENG R, Zhang M, Zhang W
    Comparison of the Efficacy of High-Flow Nasal Cannula and Bi-Level Positive Airway Pressure in Children with Asthma Exacerbation: A Systematic Review and Meta-Analysis.
    J Asthma. 2026 Feb 22:1-11. doi: 10.1080/02770903.2026.2633355.
    PubMed         Abstract available

  45. ALAGA A, Hamad NS, Cheng YZ, Hanafi N, et al
    Enhancing severe asthma referral and care through Severe Asthma Network: the experience in Kota Setar, Kedah, Malaysia.
    J Asthma. 2026 Feb 23:1-9. doi: 10.1080/02770903.2026.2633402.
    PubMed         Abstract available

  46. ZHOU X, Chen Y, Hui Y
    Transcriptome Profiling of Peripheral Blood for Inflammatory Subtype Classification and Diagnostic Model Construction in Asthma.
    J Asthma. 2026 Feb 24:1-12. doi: 10.1080/02770903.2026.2633354.
    PubMed         Abstract available

  47. YINGYING Y, Yi W, Xu H
    Association between Caregiver Social Support, Family Management, and Asthma Control in Children Aged 1-7 Years.
    J Asthma. 2026 Feb 24:1-14. doi: 10.1080/02770903.2026.2633351.
    PubMed         Abstract available

  48. ZHANG S, Cui C, Wang Z, Liu L, et al
    Development and validation of the parental Inhaled Medication Literacy Scale for school-age children with asthma (PIMLS-SA).
    J Asthma. 2026 Feb 24:1-26. doi: 10.1080/02770903.2026.2633356.
    PubMed         Abstract available

  49. KIM JH, Kim JK, Park JS, Han BE, et al
    Croup in Infancy and Subsequent Asthma Development: Is There a Link?
    J Asthma. 2026 Feb 26:1-13. doi: 10.1080/02770903.2026.2633360.
    PubMed         Abstract available


    J Invest Dermatol

  50. ZHOU T, Geng S
    Breaking the mast cell-T helper 2 axis in atopic dermatitis: Insights from oral MRGPRX2 antagonist.
    J Invest Dermatol. 2026 Jun 17:S0022-202X(26)01263.
    PubMed        


    J Pediatr

  51. MATHIESEN L, Santoro JD, Lee NJ, van Haren KP, et al
    Pediatric Neuroinflammatory and Neuropsychiatric Syndromes Associated with Dupilumab Treatment for Atopic Dermatitis.
    J Pediatr. 2026 Jun 17:115201. doi: 10.1016/j.jpeds.2026.115201.
    PubMed        


    Pediatr Dermatol

  52. SCHNEIDERMAN M, Derrick KM
    Childhood Atopic Dermatitis and Performance on Standardized Testing: A U.S. Birth Cohort Study.
    Pediatr Dermatol. 2026 Jun 14. doi: 10.1111/pde.70266.
    PubMed         Abstract available

  53. CHOKSHI A, Keelin J, Foy V, Choudhury S, et al
    Topical Janus Kinase Inhibitors for Pediatric Atopic Dermatitis: A Systematic Review of Efficacy and Safety.
    Pediatr Dermatol. 2026 Jun 14. doi: 10.1111/pde.70298.
    PubMed         Abstract available


    PLoS One

  54. MASRI D, Joulani H, Nasser A, Daraghmeh DN, et al
    Knowledge, attitudes, and practices regarding asthma management among pharmacists in palestine: A cross-sectional study.
    PLoS One. 2026;21:e0351933.
    PubMed         Abstract available


  55. Correction: Air pollution in the places of Betula pendula growth and development changes the physicochemical properties and the main allergen content of its pollen.
    PLoS One. 2026;21:e0352100.
    PubMed         Abstract available

  56. PIWOWAREK KL, Klos K, Rutkowska E, Chcialowski A, et al
    Association between results of component-resolved diagnostics and basophil activation in Hymenoptera venom allergy: A registry-based cross-sectional study in adults.
    PLoS One. 2026;21:e0350189.
    PubMed         Abstract available

  57. RYAN KA, Darpel KK, Rubenstein JH, Dellon ES, et al
    Shared decision making in Eosinophilic esophagitis: Integrating physician and patient perspectives.
    PLoS One. 2026;21:e0350662.
    PubMed         Abstract available


    Respir Med

  58. LAWSON JA, Kim M, Jandaghi P, Goodridge D, et al
    The co-existence of asthma and neurodevelopmental or mental health disorders and its association with health-related outcomes in a national sample of Canadian children.
    Respir Med. 2026;259:108915.
    PubMed         Abstract available

  59. FAYON M, Hill K, Riberi L, Dournes G, et al
    Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective (part 2: special situations/respiratory complications).
    Respir Med. 2026;259:108911.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum